NL300083I1 - 1-Beta-D-ribofuranosyl-1,2,4-triazool-3-carboxamide voor de bereiding van een geneesmiddel voor de medische behandeling van mensen. - Google Patents

1-Beta-D-ribofuranosyl-1,2,4-triazool-3-carboxamide voor de bereiding van een geneesmiddel voor de medische behandeling van mensen.

Info

Publication number
NL300083I1
NL300083I1 NL300083C NL300083C NL300083I1 NL 300083 I1 NL300083 I1 NL 300083I1 NL 300083 C NL300083 C NL 300083C NL 300083 C NL300083 C NL 300083C NL 300083 I1 NL300083 I1 NL 300083I1
Authority
NL
Netherlands
Prior art keywords
ribofuranosyl
carboxamide
triazole
humans
medical treatment
Prior art date
Application number
NL300083C
Other languages
English (en)
Original Assignee
Viratek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24673430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300083(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Viratek filed Critical Viratek
Publication of NL300083I1 publication Critical patent/NL300083I1/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NL300083C 1984-10-29 2002-02-14 1-Beta-D-ribofuranosyl-1,2,4-triazool-3-carboxamide voor de bereiding van een geneesmiddel voor de medische behandeling van mensen. NL300083I1 (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66625284A 1984-10-29 1984-10-29
EP19900105678 EP0383361A3 (en) 1984-10-29 1985-04-16 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans
EP85302644A EP0181050A3 (en) 1984-10-29 1985-04-16 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans

Publications (1)

Publication Number Publication Date
NL300083I1 true NL300083I1 (nl) 2002-05-01

Family

ID=24673430

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300083C NL300083I1 (nl) 1984-10-29 2002-02-14 1-Beta-D-ribofuranosyl-1,2,4-triazool-3-carboxamide voor de bereiding van een geneesmiddel voor de medische behandeling van mensen.

Country Status (19)

Country Link
EP (3) EP0181050A3 (nl)
JP (1) JPH0713019B2 (nl)
KR (1) KR860003018A (nl)
AT (1) ATE204173T1 (nl)
AU (1) AU584333B2 (nl)
BE (1) BE902199A (nl)
CA (1) CA1261265A (nl)
DD (1) DD261094A5 (nl)
DE (3) DE10299005I2 (nl)
ES (1) ES8704962A1 (nl)
FR (1) FR2572286B1 (nl)
GB (1) GB2166050B (nl)
HK (1) HK1010985A1 (nl)
LU (1) LU85854A1 (nl)
NL (1) NL300083I1 (nl)
NZ (1) NZ212510A (nl)
PH (1) PH22534A (nl)
PT (1) PT81387B (nl)
ZA (1) ZA858237B (nl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252962B1 (en) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis
JP2792246B2 (ja) * 1991-01-31 1998-09-03 信越半導体株式会社 単結晶棒クランプ位置決め治具及びこれを用いた単結晶棒クランプ位置決め方法
MXPA01007211A (es) * 1999-01-29 2002-05-06 Icn Pharmaceuticals Modulacion de la respuesta inmune por ribavirina.
US6720000B2 (en) 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
US7132453B2 (en) * 2002-03-15 2006-11-07 Vanderbilt University Method of using prostacyclin to treat respiratory syncytial virus infections
US7538094B2 (en) 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
EA201692515A1 (ru) 2014-06-23 2017-05-31 Сановель Илач Санайи Ве Тиджарет А.Ш. Новая фармацевтическая композиция на основе софосбувира и рибавирина
EA201692514A1 (ru) 2014-06-23 2017-04-28 Сановель Илач Санайи Ве Тиджарет А.Ш. Фармацевтические композиции на основе софосбувира и рибавирина с модифицированным высвобождением
EP2959901A1 (en) 2014-06-23 2015-12-30 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of sofosbuvir and ribavirin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3927216A (en) * 1971-06-01 1975-12-16 Icn Pharmaceuticals 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
AR205339A1 (es) * 1973-03-12 1976-04-30 Icn Pharmaceuticals Sintesis de 1,2,4-triazolo-3-carboxamidas utiles como agentes antivirales
AU564876B2 (en) * 1982-03-29 1987-08-27 Liposome Company, Inc., The Stable plurilamellar vesicles

Also Published As

Publication number Publication date
ES8704962A1 (es) 1987-04-16
HK1010985A1 (en) 1999-07-02
JPH0713019B2 (ja) 1995-02-15
JPS61109723A (ja) 1986-05-28
EP0643970A3 (en) 1997-07-09
DE3588232D1 (de) 2001-09-20
EP0643970B1 (en) 2001-08-16
AU584333B2 (en) 1989-05-25
EP0383361A3 (en) 1993-06-16
DD261094A5 (de) 1988-10-19
EP0383361A2 (en) 1990-08-22
PT81387A (en) 1985-11-01
EP0181050A3 (en) 1987-10-21
ZA858237B (en) 1988-02-24
GB2166050A (en) 1986-04-30
CA1261265A (en) 1989-09-26
BE902199A (fr) 1985-07-31
ATE204173T1 (de) 2001-09-15
ES548303A0 (es) 1987-04-16
DE10299005I1 (de) 2002-05-08
EP0643970A2 (en) 1995-03-22
DE181050T1 (de) 1986-12-18
GB2166050B (en) 1989-08-16
FR2572286B1 (fr) 1990-03-23
DE10299005I2 (de) 2004-07-01
EP0181050A2 (en) 1986-05-14
LU85854A1 (fr) 1985-12-16
KR860003018A (ko) 1986-05-19
NZ212510A (en) 1989-04-26
FR2572286A1 (fr) 1986-05-02
DE3588232T2 (de) 2002-06-13
GB8509689D0 (en) 1985-05-22
PT81387B (pt) 1987-11-11
AU4180785A (en) 1986-05-08
PH22534A (en) 1988-10-17

Similar Documents

Publication Publication Date Title
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
DE69521994D1 (de) Zusammensetzungen welche dna zerstoerende agentien und p53 enthalten
MX9504415A (es) Eteres antivirales de isoesteres de sustrato de proteasa de aspartato.
NL960024I1 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus gesmette patiënten.
NL300083I1 (nl) 1-Beta-D-ribofuranosyl-1,2,4-triazool-3-carboxamide voor de bereiding van een geneesmiddel voor de medische behandeling van mensen.
WO1997011666A3 (en) Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases
AP9400647A0 (en) Medicaments for use in treatment of HIV or cancer patients.
NO166280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n'-disubstituerte ureaer.
NO993997L (no) Anvendelse av 9,10-sekokolesta-5,7,10(19)-trien-1-3-diol, eller alfakalsidol
EP0149475A3 (en) Medicaments for the treatment and prevention of liver damage
ATE67931T1 (de) Butylhydroxyanisole zur behandlung von retrovirus-krankheiten.
WO2000002578A8 (fr) Remedes contre les maladies liees a l'apoptose
ES2042715T3 (es) Remedio medico veterinario y humano que tiene una actividad antivirial y antitumoral que contiene 2,6-diamino-3-fenil-azo-piridina.
IT8522576A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori, muscolari e articolari.
GEU1998399Y (en) Preparation “Pheroservit-1” for Increasing the Resistivity of Young Stock Against Anemia